Lv1
90 积分 2025-04-30 加入
Global burden of liver disease: 2023 update
18天前
已完结
Changing epidemiology, global trends and implications for outcomes of NAFLD
18天前
已完结
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
18天前
已完结
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
27天前
已完结
LYVAC/PDZD8 is a lysosomal vacuolator
5个月前
已完结
Lipid-induced granules in hepatocytes alleviate liver fibrosis
5个月前
已完结
Septal LYVE1+ macrophages control adipocyte stem cell adipogenic potential
5个月前
已完结
Glycyrrhetinic acid augments lipid catabolism via immune-neural modulation in adipose tissue
5个月前
已完结
Ironing out MAFLD: Therapeutic targeting of liver ferroptosis
7个月前
已完结
Hepatic glucose sensing via the CREB coactivator CRTC2
10个月前
已完结
皖公网安备34019202002308
